Since their initial investment in 2016, sTF5 Care’s support has helped advance research efforts and led to more than 32 publications in major journals, numerous awards, and recognition of lead academic Dr. Tesar’s scientific excellence and mentorship of the next generation of medical researchers. The team works to advance remyelination therapies for MS patients working with leaders around the world to further accelerate progress. sTF5 Care has helped position the School of Medicine as the global leader in myelin research, and the logical home for a Myelin Medicine Institute giving new hope to MS patients all over the world.